Axsome Therapeutics Inc.

(NASDAQ:AXSM) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and others.

Contact Information

Website: www.axsome.com
Email: mjacobson@axsome.com
Main Phone: +1 212 332-3241
Address: 22 Cortlandt Street
Address 2: 16th Floor
State: NY
City / Town: New York
Country: US
Postal Code: 10007

Issuer Information

Exchange: NSD
CEO: Herriot Tabuteau
Employees: 60
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A